Objectives: The objectives were to compare the long-term outcomes, including hysterectomy, chronic pelvic pain (CPP) and abnormal uterine bleeding (AUB), in women post hysteroscopic sterilization (HS) and laparoscopic tubal ligation (TL) in the Medicaid population. were included. Main outcome measures were hysterectomy, CPP or AUB in the 24 months poststerilization. Propensity score matching was used to control for patient demographics and baseline characteristics. Logistic regression analysis investigated the variables associated with a 24-month rate of each outcome in the HS versus laparoscopic TL cohorts. Results: Postmatching analyses were performed at 6, 12 and 24 months post index procedure. At 24 months, hysterectomy was more common in the laparoscopic TL than the HS group (3.5% vs. 2.1%; p=.0023), as was diagnosis of CPP (26.8% vs. 23.5%; p=.0050). No significant differences in AUB diagnoses were observed. Logistic regression identi ed HS as being associated with lower risk of hysterectomy ( odds ratio [OR] 0.77 [95% fi confidence interval {CI} 0.60-0.97]; p=.0274) and lower risk of CPP diagnosis (OR 0.91 [95% CI 0.83-0.99]; p= .0336) at 24 months poststerilization. Conclusion: In Medicaid patients, HS is associated with a significantly lower risk of hysterectomy or CPP diagnosis 24 months poststerilization versus laparoscopic TL. Incidence of AUB poststerilization is not significantly different. While some differences in outcomes were statistically signi cant, the effect sizes were small, and the fi conclusion is one of equivalence and not clinical superiority. Implications statement: This propensity score matching analysis confirms that pelvic pain and AUB are common in women before and after sterilization regardless of whether the procedure is performed hysteroscopically or laparoscopically. Moreover, HS is associated with a signi cantly lower risk of hysterectomy or a CPP diagnosis fi in the 24 months poststerilization when compared to TL.
Introduction
Although trends suggest a declining rate of female sterilization in the United States , it remains the second most common form of contra- [1] ception among US reproductive-aged women . Methods available [2] for interval sterilization (sterilization at a time remote from delivery) include laparoscopic tubal ligation (TL) and hysteroscopic sterilization (HS). TL requires entry into the peritoneal cavity and general anesthesia, whereas HS involves an implant being placed into the fallopian tubes through a hysteroscope.
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(chronic headache, low back pain, pelvic pain, and bromyalgia) are 6 fi times as likely to experience both acute and chronic pelvic pain (CPP) following the Essure hysteroscopic tubal sterilization procedure . [5] Women with no or public insurance are more likely to undergo steriliz ation than women with commercial insurance. African Americ an race, less education and poverty also increase the likelihood of sterilization . Current data on seque lae after sterilization are limited to [1, 6] women with commercial insurance , and it is unknown whether [3] the same outcomes can be expected in a population of women who are publicly insured.
The current study was undertaken to compare the rate of hysterectomy and the diagnosis of CPP or abnormal uterine bleeding (AUB), outcomes also explored by Perkins et al., in the 24 months after sterilization by laparoscopic TL or HS in women who were covered by Medicaid.
Materials and methods

Data source
This retrospective, observational cohort study used data from the US Medicaid Analytic Extracts (MAX) Encounters database, which contains individual-level information on characteristics of Medicaid enrollees. This database includes demographic data (e.g., age, race), information on dispensed prescription drugs identi ed by a National Drug Code, fi Medicaid services (e.g. physician services, laboratory/x-ray, clinical services, premium payments, outpatient hospital claims), institutional long-term care services and inpatient services (including dia gnoses, procedures, discharge status, length of stay and payment amount). In compliance with the Health Insurance Portability and Accountability Act of 1996, the database comprises fully deidentified data sets. Therefore, this study was exempt from Institutional Review Board overview under the Common Rule (45 CFR x46.101(b) [4] ).
Subjects
Women aged 18 to 49 years who had at least one claim for HS (Current Procedural Terminology [CPT] code: 58565) or interval laparoscopic TL ( CPT codes: 58670 or 58671) at any time during July 1, 2009, through December 31, 2010 ( Supplementary Fig. 1 ), were included in this study. The date of the claim for the sterilization procedure was defined as the index date. The study included only women who had 6 months of continuous medical and pharmacy claims data prior to the procedure and at least 24 months after the procedure. The entire study period, including baseline and follow-up, was January 1, 2009, through December 31, 2012. At the time of the analysis, 35 states were available in the 2012 MAX data.
Patients were excluded from the analysis if they underwent postpartum TL during the study period; had already undergone a sterilization procedure during the baseline period; had a claim for pregnancy or delivery within 6 weeks before the index date; had more than one type of sterilization procedure on the index date; had concurrent procedures on the same day as the index sterilization procedure that may have an impact on the study outcomes ( Supplementary Table 1 ); or had a modifier -53 next to the procedure code on the index date, indicating an incomplete procedure.
All available data that met the inclusion and exclusion criteria were included.
Analysis and outcomes
(ICD-9) diagnostic codes for pelvic pain/lower abdominal pain and AUB (Supplementary Table 2 ).
Poststerilization CPP was defined as receiving ≥2 diagnoses of pelvic pain/lower abdominal pain on at least 2 separate visit s, beginning 2 weeks post index procedure. At least one of these diagnoses had to be received at least 3 months after the index procedure (indicating some degree of chronicity). AUB was de ned as 2 diagnoses of AUB fi ≥ at least 2 weeks post index procedure with at least one of them occurring beyond 3 months after the index procedure.
Statistical analysis
All baseline and outcome variables were analyzed descriptively. Percentages and numbers were calculated for dichotomous and polychotomous variables, and compared using chi-square test with p values and 95% confidence intervals (CIs). Means with SDs were calculated for continuous variables and compared using tests, with p values and 95% CI.
t In addition, standardized differences (effect size [ES]), de ned as the abfi solute difference in sample means divided by an estimate of the pooled SD of the variable, were calculated for each variable. Standardized differences were reported as 100 times the absolute ES difference.
Patient matching was carried out in two steps by the combination of exact match of patient characteristics and propensity score matching (PSM). Exact patient match ensured that the matched patient groups have the same distribution of key baseline patient characteristics (as identified by DeNoble et al. in their study of medical comorbidities common in reproductive aged women), and included baseline pain status (as identified by Yunker et al. in their study of pelvic pain post Essure placement) and the presence of baseline AUB diagnosis codes [5, 7] . History of pain was not included in the propensity score as it would provide a good match rather than an exact match. Baseline pain and baseline AUB are considered s trong con founders that are important to be matched exactly [5, 7] . PSM was then conducted within each of the strati ed groups, and additional patient demographic and clinical characterfi istics were controlled in the PSM that enabled the matched populations to have the same and/or similar baseline characteristics. Multivariable logistic regression analysis was carried out on the entire unmatched sample as a sensitivity analysis to check on the robustness of the ndfi ings from the matching analysis. Multivariable logistic regression was used to generate the propensity score, with women having HS versus laparoscopic TL as the dependent variable, and the covariates in the PSM included a ge (18 24 [reference], 25 34, 35 44, --29, 30--39, 40-45 49); race (White [reference], African American, Hispanic, ot her race, unknown); Charlson Comorbidity Index (CCI) score (0 [reference] or 1); geographic region (North East [reference], South, Midwest, ≥ West, other); comorbidities (hypertension, asthma, hypothyroidism, diabetes, obesity); pelvic pain-related conditions ( broid, benign ovarfi ian neoplasms); prior pregnancy/delivery (during the 6-month baseline but beyond 6 weeks prior to the index date); and oral contraceptive or injectable methods used during a 6-month baseline prior to index. Logistic regressions were also conducted using the unmatched population to compare the risk of hysterectomy, CPP and AUB 24 months post-HS versus laparoscopic TL by controlling patient demographic and clinical characteristics. All statistical analyses were carried out using SAS 9.3.
Results
Patient characteristics
Overall, 14,804 women met the inclusion criteria and had at least 24 months of continuous data poststerilization; 3929 had undergone The primary outcomes measures were the proportion of women who underwent hysterectomy and were diagnosed with CPP or diagnosed with AUB at 6, 12 and 24 months post index event. Hysterectomy was identi ed based on CPT codes, and the latter two outcomes were fi ident i ed using fi Internati onal Classi cation of Diseases, Ninth Revision fi 24 months of continuous data poststerilization; 3929 had undergone HS, and 10,875 had undergone laparoscopic TL ( Supplementary Fig. 2 and ). At baseline, women in the HS cohort were older than in Table 1 the laparoscopic TL cohort (mean [SD] age 31.8 [6.1] vs. 30.4 [5.9] years, respectively; p .0001). Fewer women in the laparoscopic TL b than in the HS group had diagnosis codes for hypertension (10.2% vs.
7.7%; p .0001), diabetes (5.1% vs. 3.5%; p b b.0001) or obesity (6.6% vs. 4.7%; pb.0001 ). Fewer women in the HS group than those in the laparoscopic TL group received a diagnosis code for a pain condition (chronic headache, low back pain, pelvic pain, fibromyalgia) (35.1% vs. 40.0%; pb.0001). Baseline AUB was higher in the HS group than in the laparoscopic TL group (8.1% vs. 6.4%; p=.0004). Fewer women in the HS group used no prescription contraceptive during the baseline period (no contraceptive use: 63.7% vs. 83.7%; pb.0001). The difference in contraceptive use was most marked for oral contraceptives (8.8% in the HS group vs. 5.3% in the laparoscopic TL group; pb.0001) and for injectables (25.1% in the HS group vs. 7.5% in the laparoscopic TL group; pb.0001). There were also signi cant differences in race/ethnicity, as shown in fi Table 1 . PSM adjusted baseline characteristics were similar between both groups except for inflammato ry bowel disease and low back pain. 
Contraceptive use in the overall study population
"
" No use of prescription contraceptives poststerilization (2 weeks preindex to 3 months postindex) was significantly higher in the laparoscopic TL group compared to the HS group (97.0% vs. 77.2%; p .0001, reb spectively). The difference in c ontraceptive use poststerilization was most marked for oral contraceptives (HS, 6.4% vs. laparoscopic TL, 1.5%; p .0001) and for injectables (HS, 14.5% vs. laparoscopic TL b group, 0.8%; pb.0001).
Overall population
In an unmatched analysis, poststerilization hysterectomy and a diagnosis of CPP after sterilization were signi cantly more common in the fi laparoscopic TL group than the HS group both at 12 months and 24 months (p .005 for all) (
). The rates of AUB diagnoses after b Table 2 sterilization procedure were signi cantly more common in the HS fi group than the laparoscopic TL group at 12 months (p=.0059) but not at 24 months (p=.3145) ( Table 2 ).
Postmatching analysis
At 6 months, there were no significant differences between the laparoscopic TL group and the HS group in the rates of poststerilization hysterectomy, diagnosis of CPP or diagnosis of AUB (Table 3 ). Hysterectomy was significantly more common in the laparoscopic TL group than the HS group at 24 months (3.5% vs. 2.1%; p=.0023). A diagnosis of CPP after sterilization was significantly more common in the laparoscopic TL group than the HS group at 12 months (13.8% vs. 11.7%; p=.0215) and 24 months (26.8% vs. 23.5%; p=.0050). There were no significant differences in the rates of AUB diagnoses after sterilization procedure at 12 months (p=.4334) and 24 months (p=.7629).
Logistic regression analysis
Logistic regres sion identi ed HS as being associated with a lower fi risk of hysterectomy (odds ratio [OR] 0. 77 [95% CI 0.60-0.97]; p= .0274) or a CPP diagnosis (OR 0.91 [95% CI 0.8 3 0.99]; p=.0336) in the 24 months poststerilization; there was a similar risk of AUB compared to laparoscopic TL (Table 4 ).
Discussion
Both unmatched and PSM analyses of Medicaid patients indicate that pelvic pain and AUB are common in women before and after sterilization whether the procedure is performed hysteroscopically or laparoscopically. Moreover, HS is associated with a significantly lower risk of hysterectomy at 24 months or a CPP diagnosis at 12 a nd 24 months poststerilization when compared to TL, consistent with earlier reports [3] . Higher rates of AUB were found in the unmatched comparison at 6 and 12 months but not at 24 month s; there were no differences in AUB at any time point in the matched analysis.
Consistent with previous reports [8] , the publicly insured women in our study underwent sterilization at an average age of about 30 years compared to a mean age of about 37 years for commercially insu red women. [3, 8] . Consistent with our data, a comparison of Medicaid and commercially insured women undergoing HS or TL found that the Medicaid cohort was more likely to be using an injectable contraceptive and less likely to be using an oral contraceptive prior to sterilization . [8] Medicaid patients had a higher mean CCI score and were more likely to be obese or to have asthma than commercially insured women but less likely to have hypothyroidism [8] .
Previous researchers found a significant difference in the rate of AUB during the first year following HS versus TL [3] . This potentially may be explained by the need to continue contraception after HS until a confirmation test has demonstrated proper insert location. Therefore, in the first several months after HS, women are still experiencing the effects of taking, then withdrawing from, hormonal contraception, whereas women undergoing TL can cease using contraceptives immediately after sterilization. In our matched analysis, however, the rate of AUB was similar at 6, 12 and 24 months postprocedure ( Table 3) . Logistic regression analysis in our study cohort identi ed baseline obesity, race (African fi American, Hispanic, other), pain condition, AUB and the use of injectable contraceptives as risk factors for an AUB diagnosis after sterilization.
Reports have emerged about pain developing after HS [5, 9, 10] , but until recently, the studies comparing outcomes after HS and TL were limited by their definit ions of pain (e.g., severe pain requiring opioids) [4] or by their short duration of follow-up [11] . In using a definition of pain that was consistent with previous research [3] , we found a higher rate of CPP diagnosis after sterilization in patients who underwent TL compared with those who underwent HS (26.8% vs. 23.5%). While the rate of CPP was significantly higher in the TL versus the HS group in this study, the difference is small and unlikely to represent a clinically important difference. Nevertheless, the data from this study are consistent with Perkins et al. in that HS is not associated with more CPP than is TL [3] .
These data are an important adjunct to previous database analyses, which have used data from employer-based insurance plans and ex- [3] clude d Me dicaid or Medicare patients. According to the Women's [12] insurance. Therefore, although our data set is representative of only a small proportion of US women, it is a cohort in whom outcomes after sterilization have not been previously studied in detail. Database analyses have limitations. The comorbidities and diagnoses used are based solely on ICD-9 or CPT codes, and there is potential for coding errors to occur during data entry. The MAX database has 2012 data for only 35 states; however, the data come from all regions of the United States and are therefore likely to be nationally representative. MAX files contain only Medicaid-paid services and do not capture service use or expenditures during periods of nonenrollment, services paid by other payers or services provided at no charge. This database consists of claims submitted by healthc are providers to insurance companies for reimbursement on behalf of individuals, probably contributing to underreporting of AUB and pelvic pain events as many patients experience these conditions without consulting a healthcare professional [13, 14] . In addition, other limitations may be associated with claims data use because data are collected for the purpose of payment and not research. Comorbidities and diagnoses were based solely on ICD-9 or CPT codes. Operationalization of A strength of our analysis was the exclusion of women who had concomitant gynecologic procedures on the index sterilization date that could have an impact on the study outcome measures. Because many of these procedures are more likely to be performed in one study cohort than the other (eg, lysis of adhesions will only be performed in the laparoscopic group), allowing these additionally treated subjects to remain in the analysis woul d create an uncontrollable bias. An additional strength of our analysis is the use of the pro pensity score mod el, which included all measured baseline covariates potentially associated with treatment assignment and outcomes.
In conclusion, our data demonstrate that the incidence of hysterectomy and CPP in publicly insured women is lower after HS compared to after TL. In propensity score matched analyses, HS is associated with lower odds of having a hysterectomy at 24 months or receiving a diagnosis of CPP at 12 and 24 months, but not 6 months, after steriliza- Table 4 Logistic regression analysis examining the OR of having different outcomes at 24 months based on type of sterilization procedure and baseline characteristics.
Hysterectomy
Pelvic pain AUB agnoses were based solely on ICD-9 or CPT codes. Operationalization of concepts, such as CPP and AUB, must rely on the frequency of the codes reported as clinical records are not available. In addition, other variables, such as level of education and socioeconomic status, are known to affect reports of chronic pelvic pain, AUB and hysterectomy [15] . It is unknown how unmeasured variables such as these would affect these analyses.
diagnosis of CPP at 12 and 24 months, but not 6 months, after sterilization compared to TL. The clinical relevance of these ndings is uncertain fi given the small absolute difference in rates. The incidence rates of AUB at 6, 12 and 24 months poststerilization were similar in women who underwent HS compared to TL ( ). Logistic regression analyses Table 3 support these findings.
Supplementary data to this article can be found online at https://doi. org/10.1016/j.contraception.2017.12.015.
